01-07-2025 19:57 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Zydus Lifesciences Ltd.
Change Company   
BSE Code 532321
ISIN Demat INE010B01027
Book Value 210.59
NSE Code ZYDUSLIFE
Dividend Yield % 1.10
Market Cap 1007693.03
P/E 17.45
EPS 57.39
Face Value 1  
19-Jun-2025 USFDA concludes GMP follow-up inspection at Zydus...
19-Jun-2025 Zydus Lifesciences informs about investor confer...
19-Jun-2025 Announcement under Regulation 30 (LODR)-Press Re...
12-Jun-2025 Zydus Lifesciences gets EIR for Ankleshwar API ma...
12-Jun-2025 Zydus Lifesciences gains on getting EIR for Ankle...
10-Jun-2025 Zydus Lifesciences gets EIR for Vadodara API manu...
04-Jun-2025 Zydus Lifesciences’ arm enters into SPA with Agen...
04-Jun-2025 Zydus Lifesciences trades marginally higher as it...
02-Jun-2025 Zydus Lifesciences gets USFDA’s tentative approva...
02-Jun-2025 Zydus Lifesciences informs about press release
29-May-2025 Zydus Lifesciences to subscribe equity shares of ...
29-May-2025 Zydus Lifesciences gains on entering to SSSA to s...
28-May-2025 Zydus Lifesciences’ NCE Usnoflast receives Fast T...
28-May-2025 Zydus Lifesciences informs about press release
28-May-2025 Zydus Lifesciences rises as its NCE Usnoflast rec...
Page 1 of 6
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.